ABPI, Serious Fraud Office explain enforcement policy on UK Bribery Act and industry code breaches
This article was originally published in SRA
Executive Summary
Ahead of the UK Bribery Act coming into effect on 1 July, the Association of the British Pharmaceutical Industry and the Serious Fraud Office have issued clarification on which of the two parties is likely to lead on enforcement in cases where a breach of the ABPI's code of practice is also a potential breach of the new legislation1,2.